Michael G. Erickson - 17 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Feb 2026, 18:00:27 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael G. Erickson

Key filing fact

Michael G. Erickson filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 19 Feb 2026.

Key facts

  • This page summarizes Michael G. Erickson's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
  • 20 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2026, 18:00.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$1,909,337.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002005385 Primary reporting owner

Erickson Michael G

Relationship
Executive Vice President
Address
ONE IDEXX DRIVE, WESTBROOK
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael G. Erickson
Signature date
19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value
$168,646
Shares
+1,191
Change %
+9.4%
Price
$141.60
Shares after
13,884
Date
17 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$745,127
Shares
+4,180
Change %
+30%
Price
$178.26
Shares after
18,064
Date
17 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Sale

Transaction value
$284,434
Shares
-456
Change %
-2.5%
Price
$623.76
Shares after
17,608
Date
17 Feb 2026
Ownership
Direct
Footnotes
F1
IDXX transaction

Common Stock

Sale

Transaction value
$127,549
Shares
-204
Change %
-1.2%
Price
$625.24
Shares after
17,404
Date
17 Feb 2026
Ownership
Direct
Footnotes
F2
IDXX transaction

Common Stock

Sale

Transaction value
$806,618
Shares
-1,288
Change %
-7.4%
Price
$626.26
Shares after
16,116
Date
17 Feb 2026
Ownership
Direct
Footnotes
F3
IDXX transaction

Common Stock

Sale

Transaction value
$1,692,427
Shares
-2,694
Change %
-17%
Price
$628.22
Shares after
13,422
Date
17 Feb 2026
Ownership
Direct
Footnotes
F4
IDXX transaction

Common Stock

Sale

Transaction value
$433,443
Shares
-689
Change %
-5.1%
Price
$629.09
Shares after
12,733
Date
17 Feb 2026
Ownership
Direct
Footnotes
F5
IDXX transaction

Common Stock

Sale

Transaction value
$25,194
Shares
-40
Change %
-0.31%
Price
$629.86
Shares after
12,693
Date
17 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$101,810
Shares
+719
Change %
+5.7%
Price
$141.60
Shares after
13,412
Date
19 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$145,638
Shares
+817
Change %
+6.1%
Price
$178.26
Shares after
14,229
Date
19 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$99,952
Shares
+483
Change %
+3.4%
Price
$206.94
Shares after
14,712
Date
19 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$99,567
Shares
+183
Change %
+1.2%
Price
$544.08
Shares after
14,895
Date
19 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$99,589
Shares
+197
Change %
+1.3%
Price
$505.53
Shares after
15,092
Date
19 Feb 2026
Ownership
Direct
Footnotes
F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-1,191
Change %
-100%
Price
$0.000000
Shares after
0
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,191
Exercise price
$141.60
Footnotes
F7
IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-4,180
Change %
-100%
Price
$0.000000
Shares after
0
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,180
Exercise price
$178.26
Footnotes
F8
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-719
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
719
Exercise price
$141.60
Footnotes
F9
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-817
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
817
Exercise price
$178.26
Footnotes
F10
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-483
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
483
Exercise price
$206.94
Footnotes
F11
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-183
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
183
Exercise price
$544.08
Footnotes
F12
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-197
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
197
Exercise price
$505.53
Footnotes
F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Represents the weighted average price of the shares sold ranging from a low of $623.28 to a high of $624.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F2

Represents the weighted average price of the shares sold ranging from a low of $624.89 to a high of $625.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F3

Represents the weighted average price of the shares sold ranging from a low of $626.045 to a high of $628.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F4

Represents the weighted average price of the shares sold ranging from a low of $627.74 to a high of $628.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F5

Represents the weighted average price of the shares sold ranging from a low of $628.755 to a high of $629.615 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F6

Includes 184 vested but deferred restricted stock units.

Footnote F7

Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018.

Footnote F8

Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning on February 14, 2019.

Footnote F9

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2022.

Footnote F10

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2023.

Footnote F11

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.

Footnote F12

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.

Footnote F13

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .